Leaseir MHR Xcell (console MHR-100b); Handpiece Dual (810-b and Blend-b); Handpiece Quad (810-b and Blend-b)
510(k) K253251
Active
Valid until
Not listed
FDA recalls
None foundTrust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE 510(k) | NumberK253251 | Date4 May 2026 | StatusActive |
| European Union | CE/MDR EUDAMED | Number— | Date— | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
- European Union
- United States
Specification
- 510(k) Number
- FDA Product Code
- GEX
- Device Class
- Class II
- Regulation
- 21 CFR Part 878.4810
- Advisory Committee
- General, Plastic Surgery
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 18 Sep 2026
The Leaseir MHR Xcell is a powered laser system designed for soft tissue ablation and coagulation in surgical procedures. It operates using dual and quad handpieces with 810-nanometer and blend-mode wavelengths, enabling precise control for procedures in general and plastic surgery.
This device is supplied as a console (MHR-100b) paired with interchangeable handpieces, intended for reusable use in controlled clinical settings. It complies with FDA 510(k) clearance (K253251) under 21 CFR 878.4810 and EU MDR regulations, with no third-party involvement. Sterility and MRI safety are not specified in the data.
Other devices from Leaseir Technologies, S.L.U.
Questions
AI-generated answers, 18 Sep 2026
What types of surgical procedures is the Leaseir MHR Xcell system primarily intended for?
The Leaseir MHR Xcell system is designed for soft tissue ablation and coagulation during surgical procedures, particularly in general and plastic surgery. Its dual and quad handpieces, operating at 810-nanometer and blend-mode wavelengths, allow for precise control in these specialties.
How is the Leaseir MHR Xcell system supplied, and is it intended for single-use or reusable applications?
The system is supplied as a console (MHR-100b) paired with interchangeable handpieces (Dual and Quad models). It is explicitly intended for reusable use in controlled clinical settings, meaning it is not a single-use device.
What regulatory pathways has the Leaseir MHR Xcell system followed, and where is it authorized for use?
The device has received FDA 510(k) clearance (K253251) under 21 CFR 878.4810 and EU MDR compliance, with no third-party involvement. This means it is authorized for use in the U.S. and the European Economic Area under these respective regulatory frameworks.
Does the Leaseir MHR Xcell system include multiple handpiece options, and what wavelengths do they use?
Yes, the system includes two types of handpieces: a Dual handpiece (810-b and Blend-b) and a Quad handpiece (810-b and Blend-b). Both operate at 810-nanometer and blend-mode wavelengths, enabling flexibility in surgical precision.
Is the Leaseir MHR Xcell system compatible with MRI environments, and what is its sterility status?
The provided data does not specify MRI safety or sterility for the Leaseir MHR Xcell system. Clinicians should verify compatibility with their facility’s MRI protocols and follow manufacturer guidelines for sterilization if reuse is required.